TNF inhibitors are being used in a rapidly expanding number of rheumatoid arthritis (RA) patients due to their effectiveness and acceptable safety profiles. To date, concerns regarding the adverse effects of TNF inhibitors have focused on infections, hematologic malignancies, and demyelinating disorders. Recently, the development of autoantibodies and other autoimmunity has been increasingly reported. Here, we describe a 36-year-old RA patient in whom organizing pneumonia and systemic lupus erythematosus were detected during etanercept treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00296-009-1350-4 | DOI Listing |
Publication Analysis
Top Keywords
organizing pneumonia
8
rheumatoid arthritis
8
tnf inhibitors
8
etanercept induced
4
induced organizing
4
pneumonia patient
4
patient rheumatoid
4
arthritis tnf
4
inhibitors rapidly
4
rapidly expanding
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!